Successful treatment of subcorneal pustular dermatosis (Sneddon-wilkinson disease) by acitretin: report of a case.

We report a case of subcorneal pustular dermatosis (SPD) first treated with dapsone with poor response. Dapsone was changed to acitretin, which dramatically improved the lesions in a few days. Dapsone is the first-line treatment in SPD, but it may be ineffective in some cases and its toxicity is important. Therapeutic alternatives are limited and less effective (systemic corticosteroids, phototherapy). Our observation underlines the usefulness of retinoids, when dapsone is ineffective or poorly tolerated. Their effectiveness is comparable, but they are effective more rapidly and are better tolerated. A dose maintenance is necessary to avoid relapses. Their action in SPD remains unclear but may be due to the inhibition of neutrophil functions.
AuthorsV Marlière, M Beylot-Barry, C Beylot, M Doutre
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 199 Issue 2 Pg. 153-5 ( 1999) ISSN: 1018-8665 [Print] SWITZERLAND
PMID10559583 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Immunoglobulin A
  • Keratolytic Agents
  • Dapsone
  • Acitretin
  • Acitretin (therapeutic use)
  • Dapsone (therapeutic use)
  • Humans
  • Immunoglobulin A (blood)
  • Keratolytic Agents (therapeutic use)
  • Male
  • Middle Aged
  • Neutrophils (pathology)
  • Skin Diseases, Vesiculobullous (blood, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: